Cargando…

Fine mapping of the hereditary haemorrhagic telangiectasia (HHT)3 locus on chromosome 5 excludes VE-Cadherin-2, Sprouty4 and other interval genes

BACKGROUND: There is significant interest in new loci for the inherited condition hereditary haemorrhagic telangiectasia (HHT) because the known disease genes encode proteins involved in vascular transforming growth factor (TGF)-β signalling pathways, and the disease phenotype appears to be unmasked...

Descripción completa

Detalles Bibliográficos
Autores principales:	Govani, Fatima S, Shovlin, Claire L
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2010
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2924844/ https://www.ncbi.nlm.nih.gov/pubmed/20701797 http://dx.doi.org/10.1186/2040-2384-2-15

Ejemplares similares

Quality of life in patients with hereditary haemorrhagic telangiectasia (HHT)
por: Zarrabeitia, Roberto, et al.
Publicado: (2017)

European Reference Network For Rare Vascular Diseases (VASCERN) Outcome Measures For Hereditary Haemorrhagic Telangiectasia (HHT)
por: Shovlin, Claire L., et al.
Publicado: (2018)

Hereditary Hemorrhagic Telangiectasia (HHT) and Survival: The Importance of Systematic Screening and Treatment in HHT Centers of Excellence
por: de Gussem, Els M., et al.
Publicado: (2020)

European Reference Network for Rare Vascular Diseases (VASCERN) position statement on cerebral screening in adults and children with hereditary haemorrhagic telangiectasia (HHT)
por: Eker, Omer F., et al.
Publicado: (2020)

Whole genome sequences discriminate hereditary hemorrhagic telangiectasia phenotypes by non-HHT deleterious DNA variation
por: Joyce, Katie E., et al.
Publicado: (2022)

Embolisation of PAVMs reported to improve nosebleeds by a subgroup of patients with hereditary haemorrhagic telangiectasia
por: Shovlin, Claire L., et al.
Publicado: (2016)

Specific cancer rates may differ in patients with hereditary haemorrhagic telangiectasia compared to controls
por: Hosman, Anna E, et al.
Publicado: (2013)

Unsupervised machine learning algorithms identify expected haemorrhage relationships but define unexplained coagulation profiles mapping to thrombotic phenotypes in hereditary haemorrhagic telangiectasia
por: Mukhtar, Ghazel, et al.
Publicado: (2023)

A case report of hepatopulmonary syndrome in hereditary hemorrhagic telangiectasia (HHT): Not all right-to-left shunting in HHT is due to pulmonary arteriovenous malformations
por: Krishnan, Sheila, et al.
Publicado: (2018)

Pulmonary arteriovenous malformations may be the only clinical criterion present in genetically confirmed hereditary haemorrhagic telangiectasia
por: Anderson, Emily, et al.
Publicado: (2022)

Intra-venous bevacizumab in hereditary hemorrhagic telangiectasia (HHT): A retrospective study of 46 patients
por: Guilhem, Alexandre, et al.
Publicado: (2017)

Prospective pilot study of Floseal® for the treatment of anterior epistaxis in patients with hereditary hemorrhagic telangiectasia (HHT)
por: Lee, John M., et al.
Publicado: (2019)

Hereditary Hæmorrhagic Telangiectasia with Recurring Hæmaturia
por: Foggie, W. E.
Publicado: (1928)

Screening for pulmonary and brain vascular malformations is the North American standard of care for patients with hereditary hemorrhagic telangiectasia (HHT): A survey of HHT Centers of Excellence
por: Kilian, Alexandra, et al.
Publicado: (2020)

Circulatory contributors to the phenotype in hereditary hemorrhagic telangiectasia
por: Shovlin, Claire L.
Publicado: (2015)

Antithrombotic Therapy in Hereditary Hemorrhagic Telangiectasia: Real-World Data from the Gemelli Hospital HHT Registry
por: Gaetani, Eleonora, et al.
Publicado: (2020)

Systemic bevacizumab for high-output cardiac failure in hereditary hemorrhagic telangiectasia: an international survey of HHT centers
por: Al-Samkari, Hanny, et al.
Publicado: (2019)

Peliosis hepatis associated with hereditary haemorrhagic telangiectasia
por: Alessandrino, F., et al.
Publicado: (2013)

Life expextancy of parents with Hereditary Haemorrhagic Telangiectasia
por: de Gussem, E. M., et al.
Publicado: (2016)

Hereditary Haemorrhagic Telangiectasia: With Report of a Case
por: McEwan, Tom
Publicado: (1948)

Pulmonary Arterial Hypertension and Hereditary Haemorrhagic Telangiectasia
por: Vorselaars, Veronique M. M., et al.
Publicado: (2018)

Pitfalls of delaying the diagnosis of hereditary haemorrhagic telangiectasia
por: Major, Tamás, et al.
Publicado: (2019)

Hereditary haemorrhagic telangiectasia: A case report
por: Mufti, Asfandyar, et al.
Publicado: (2021)

Development and validation of a quality of life measurement scale specific to hereditary hemorrhagic telangiectasia: the QoL-HHT
por: Le, Thi Thao Truc, et al.
Publicado: (2022)

Hereditary haemorrhagic telangiectasia and pregnancy: a review of the literature
por: Dupuis, Olivier, et al.
Publicado: (2020)

Topical Propranolol Improves Epistaxis Control in Hereditary Hemorrhagic Telangiectasia (HHT): A Randomized Double-Blind Placebo-Controlled Trial
por: Mei-Zahav, Meir, et al.
Publicado: (2020)

Diode laser in the treatment of epistaxis in patients with hereditary haemorrhagic telangiectasia
por: FIORELLA, M.L., et al.
Publicado: (2012)

Altered hypoxia inducible factor regulation in hereditary haemorrhagic telangiectasia
por: Wrobeln, Anna, et al.
Publicado: (2022)

Endoglin involvement in integrin-mediated cell adhesion as a putative pathogenic mechanism in hereditary hemorrhagic telangiectasia type 1 (HHT1)
por: Rossi, Elisa, et al.
Publicado: (2015)

Neurologic Manifestation as Initial Presentation in a Case of Hereditary Haemorrhagic Telangiectasia
por: Teo, Yeow Kwan, et al.
Publicado: (2010)

Long Non-Coding RNA Expression Profiles in Hereditary Haemorrhagic Telangiectasia
por: Tørring, Pernille M., et al.
Publicado: (2014)

Liver transplantation in a patient with hereditary haemorrhagic telangiectasia and pulmonary hypertension
por: Ejiri, Kentaro, et al.
Publicado: (2019)

Endoscopic surgical treatment of epistaxis in hereditary haemorrhagic telangiectasia: our experience
por: Pagella, Fabio, et al.
Publicado: (2021)

Pulmonary hypertension in hereditary haemorrhagic telangiectasia is associated with multiple clinical conditions
por: Margelidon-Cozzolino, Victor, et al.
Publicado: (2021)

An update on preclinical models of hereditary haemorrhagic telangiectasia: Insights into disease mechanisms
por: Arthur, Helen M., et al.
Publicado: (2022)

Obstetrical and neonatal complications in hereditary haemorrhagic telangiectasia: A retrospective study
por: Delagrange, Laura, et al.
Publicado: (2022)

Safety of thalidomide and bevacizumab in patients with hereditary hemorrhagic telangiectasia
por: Buscarini, Elisabetta, et al.
Publicado: (2019)

Complications and clinical outcome of hepatic artery embolisation in patients with hereditary haemorrhagic telangiectasia
por: Chavan, Ajay, et al.
Publicado: (2012)

Raloxifene and Bevacizumab for severe complications of hereditary haemorrhagic telangiectasia in a haemodialysis patient
por: Morales, Enrique, et al.
Publicado: (2012)

Endoglin is a conserved regulator of vasculogenesis in zebrafish – implications for hereditary haemorrhagic telangiectasia
por: Zhang, Ding, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_kuhajadeihka9k85m8rk0m6cc4